BNCCORP Stockholders Approve Merger With OppFi

Consumer advocacy groups and Illinois Attorney General Kwame Raoul oppose Chicago-based OppFi's $130M bid to acquire BNCCORP, arguing it would allow high-interest loans bypassing state caps. OppFi plans to relocate to Utah post-acquisition, with regulatory approval pending. The company markets loans to underserved consumers, but critics cite high charge-off rates and predatory practices. OppFi disputes these claims, highlighting its mission to expand credit access. Enova International's similar

OppFi (OPFI) reported Q2 2026 revenue of $145.2M, up 1.9% YoY, but adjusted net income fell to $28.8M (down 27%) and adjusted EPS to $0.33 (from $0.45). Net charge-offs rose to 39.5% of revenue. Full-year 2026 guidance was revised to $600M-$625M revenue and $115M-$130M adjusted net income. Management cited product and system timing delays and outlined OCC filings for the BNC National Bank acquisition.

OppFi Inc. (OPFI) filed an SEC Form 8-K — Results of Operations and Financial Condition. NEWS RELEASE OppFi Reports Second Quarter 2026 Results, Record Second Quarter Revenue 2026-08-10 Total revenue increased 1.9% year over year to $145.2 million, a Company record for any second quarter Net income increased 36.0% year over year to $15.6 million CHICAGO, Aug. 10, 202

Attorneys general asked the Federal Reserve, OCC and FDIC to deny banking privileges tied to OppFi’s $130M acquisition of BNCCORP and BNC National Bank and Enova’s proposed acquisition of Grasshopper Bancorp and Grasshopper Bank. AGs allege bank partnerships bypass state loan-rate caps and cite high rates and charge-offs. OppFi and Enova project deposit and revenue synergies and EPS accretion.

Twenty state attorneys general urged federal banking regulators to reject Enova International’s proposed acquisition of Grasshopper Bank and OppFi’s proposed purchase of BNC National Bank’s holding company. The AGs cite concerns that bank charters could bypass state usury limits and enable nationwide triple-digit APR lending. Enova’s deal is about $369 million; OppFi’s is about $130 million.

Telix Pharmaceuticals will acquire ITM Isotope Technologies Munich for $1.65 billion, including $1.25 billion in Telix shares and $302 million in assumed debt. The deal expands Telix's radiopharmaceutical market presence and global isotope supply. ITM generated $273 million in 2025 revenue, with a 40% CAGR since 2021. Additional payments of up to $700 million are possible if ITM-11 meets milestones. The acquisition is expected to close by the end of 2026, subject to approvals.